RecruitingPhase 2NCT06638944
Wearable Biofeedback for Swallowing Disorders Rehabilitation in Stroke and Parkinson Disease
Sponsor: University of Illinois at Urbana-Champaign
Champaign, IL · West Lafayette, IN
Phase 2 Parkinson's Disease clinical trials
29 recruiting Phase 2 parkinson's disease studies in the US. What trial phases mean
Other phases
RecruitingPhase 2NCT05700825
Rehabilitation of Airway Protection in Parkinson's Disease
Sponsor: Teachers College, Columbia University
West Lafayette, IN · New York, NY
RecruitingPhase 2NCT06996652
An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD)
Sponsor: Yale University
Los Angeles, CA · Aurora, CO · North Haven, CT · +15 more sites
RecruitingPhase 2NCT07432958
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
Sponsor: Appello Pharmaceuticals, Inc.
Little Rock, AR · Carlsbad, CA · Los Alamitos, CA · +27 more sites
RecruitingPhase 2NCT06680830
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
Sponsor: Neuron23 Inc.
Sun City, AZ · Little Rock, AR · Fresno, CA · +42 more sites
RecruitingPhase 2NCT06780085
A Study of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01H/KEYMAKER-U01)
Sponsor: Merck Sharp & Dohme LLC
Lexington, KY · Baltimore, MD · Pittsburgh, PA
RecruitingPhase 2NCT06961006
A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)
Sponsor: Merck Sharp & Dohme LLC
Springdale, AR · San Francisco, CA · Hackensack, NJ · +2 more sites
RecruitingPhase 2NCT07610369
The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease
Sponsor: Yale University
New Haven, CT
RecruitingPhase 2NCT07005180
Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's Disease
Sponsor: Hillhurst Biopharmaceuticals, Inc.
Fountain Valley, CA · Gainesville, FL · Boston, MA · +5 more sites
RecruitingPhase 2NCT07830654
This Protocol is a Sub-study Under the PPMI Program. It is a Longitudinal, Single-center Study to Assess the Performance of [18F]AV-133 Imaging Using High and Standard Resolution PET in Individuals Enrolled With Parkinson's Disease (PD) for up to 12 Months.
Sponsor: Michael J. Fox Foundation for Parkinson's Research
New Haven, CT
RecruitingPhase 2NCT07592767
RESvEraTrol in Parkinson's Disease (RESET)
Sponsor: Georgetown University
Washington D.C., DC
RecruitingPhase 2NCT07002034
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Sponsor: Reunion Neuroscience Inc
Birmingham, AL · Tucson, AZ · San Diego, CA · +29 more sites
RecruitingPhase 2NCT07804615
A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
Sponsor: Vima Therapeutics
Scottsdale, AZ · Murrieta, CA · +26 more sites
RecruitingPhase 2NCT07809438
A Comparative Performance Study Between High and Standard Resolution Positron Emission Tomography Camera Using [18F] AV-133 in Prodromal Parkinson's Disease
Sponsor: Michael J. Fox Foundation for Parkinson's Research
New Haven, CT
RecruitingPhase 2NCT07514858
A Trial Investigating Lu AF28996 in Adults With Parkinson's Disease Who Have Motor Fluctuations
Sponsor: H. Lundbeck A/S
Farmington Hills, MI · Round Rock, TX
RecruitingPhase 2NCT07252739
KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)
Sponsor: Merck Sharp & Dohme LLC
Clermont, FL · Fargo, ND · Sioux Falls, SD
RecruitingPhase 2NCT07020026
Evaluation of Tau-Pathology in Sporadic and LRRK2 Parkinson's Disease
Sponsor: Michael J. Fox Foundation for Parkinson's Research
New Haven, CT
RecruitingPhase 2NCT06455293
Psilocybin Therapy for Depression in Parkinson's Disease
Sponsor: Joshua Woolley, MD, PhD
San Francisco, CA
RecruitingPhase 2NCT07442747
Neural Mechanisms of Aerobic Exercise Benefits in PD With DBS
Sponsor: The Cleveland Clinic
Cleveland, OH
RecruitingPhase 2NCT05266417
Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's Disease
Sponsor: Gateway Institute for Brain Research
Davie, FL · Hialeah, FL · Miami, FL · +1 more sites
RecruitingPhase 2NCT07176286
18F-mFBG Cardiac Uptake With Lewy Body Dementia
Sponsor: Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC)
Houston, TX
RecruitingPhase 2NCT06231563
Ketamine for Veterans With Parkinson's Disease
Sponsor: VA Office of Research and Development
San Francisco, CA
RecruitingPhase 2NCT06679374
Reducing Falls With Varenicline in Hypocholinergic Parkinson Disease
Sponsor: Vikas Kotagal
Ann Arbor, MI
RecruitingPhase 2NCT06402955
Imaging Depression in Parkinson's Disease
Sponsor: Yale University
New Haven, CT
RecruitingPhase 2NCT05603715
Pyridostigmine for the Treatment of Constipation in Parkinson Disease
Sponsor: University of Vermont Medical Center
Burlington, VT
RecruitingPhase 2NCT07265596
Early Longitudinal Imaging in the Parkinson's Progressive Marker Initiative (PPMI) Using (18F)AV-133 (PPMI AV-133 Prodromal Imaging)
Sponsor: Michael J. Fox Foundation for Parkinson's Research
New Haven, CT · Philadelphia, PA
RecruitingPhase 2NCT06460038
Tenapanor in Synucleinopathy-Related Constipation
Sponsor: Cedar Valley Digestive Health Center
Waterloo, IA
RecruitingPhase 2NCT03753243
Neoadjuvant Pembrolizumab Plus Androgen Axis Blockade Prior to Prostatectomy for High Risk Localized Prostate Cancer
Sponsor: Mark Garzotto, MD
Portland, OR
Not yet recruitingPhase 2NCT07215403
Prescriptive Infusion Algorithm (PIA)
Sponsor: AskBio Inc
Cleveland, OH · Columbus, OH · Pittsburgh, PA · +1 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.